Home/Pipeline/PidPort AI Analysis

PidPort AI Analysis

Pathological screening of tissue and cells

CommercialActive

Key Facts

Indication
Pathological screening of tissue and cells
Phase
Commercial
Status
Active
Company

About Medmain

Medmain develops and operates PidPort, an AI-powered analytical system for pathological image diagnosis and remote telepathology services.

View full company profile

Therapeutic Areas